Researchers at Mass General Hospital have been testing a new pill route of administration for fecal transplants. Twenty patients in a small, prelim trial were given frozen pills to take over two days. The results, published in JAMA, yielded cures for 19 out of the 20, with no reported side effects. So what's next on the 'poop pill-popping' research horizon?
'Poop Pills' for C. diff Infection: A New Way to Administer Fecal Transplants
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Researchers at Mass General Hospital have been testing a new pill route of administration for fecal transplants. Twenty patients in a small, prelim trial were given frozen pills to take over two days. The results, published in JAMA, yielded cures for 19 out of the 20, with no reported side effects. So what's next on the 'poop pill-popping' research horizon?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
FCS and SHTG: Are We Meeting the Need?
0.25 credits
<p>FCS and SHTG: Are We Meeting the Need?</p>
MinuteCE®
From Awareness to Action: What To Do With a Positive OSA Screen?
0.50 credits
<p>From Awareness to Action: What To Do With a Positive OSA Screen?</p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
CME/CE Broadcast Replay
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
1.00 credits
<p>Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
CME/CE Broadcast Replay
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
0.75 credits
<p>Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care</p>
CME/CE
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
0.50 credits
<p><span data-contrast="auto" xml:lang="EN-US">Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow</span><span data-ccp-props='{"201341983":0,"335559739":0,"335559740":240}'> </span></p>
CME/CE
Personalizing Care Within the RCC Treatment Paradigm
1.00 credits
<p>Personalizing Care Within the RCC Treatment Paradigm</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?